{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:24:19Z","timestamp":1790846659894,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,8,24]],"date-time":"2008-08-24T00:00:00Z","timestamp":1219536000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p>\n                    <jats:bold>Objective:\u2002<\/jats:bold>\n                    Long\u2010term antidepressant (AD) treatment for depression in bipolar disorder (BPD) patients is highly prevalent, but its benefits and risks remain uncertain, encouraging this meta\u2010analysis of available research.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Method:\u2002<\/jats:bold>\n                    We reviewed randomized controlled trials for BPD involving \u22656\u2003months of treatment with AD\u2003\u00b1\u2003mood stabilizer (MS) vs. placebo\u2003\u00b1\u2003MS, using meta\u2010analyses to compare reported risks of new depression vs. mania.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    In seven trials (350 BPD patients) involving 12 contrasts, long\u2010term treatments that included ADs yielded 27% lower risk of new depression vs. MS\u2010only or no treatment [pooled relative risk, RR\u2003=\u20030.73; 95% CI 0.55\u20130.97; number\u2010needed\u2010to\u2010treat (NNT)\u2003=\u200311], but 72% greater risk for new mania [RR\u2003=\u20031.72; 95% CI 1.23\u20132.41; number\u2010needed\u2010to\u2010harm (NNH)\u2003=\u20037]. Compared with giving an MS\u2010alone, adding an AD yielded neither major protection from depression (RR\u2003=\u20030.84; 95% CI 0.56\u20131.27; NNT\u2003=\u200316) nor substantial increase in risk of mania (RR\u2003=\u20031.37; 95% CI 0.81\u20132.33; NNH\u2003=\u200316).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:\u2002<\/jats:bold>\n                    Long\u2010term adjunctive AD treatment was not superior to MS\u2010alone in BPD, further encouraging reliance on MSs as the cornerstone of prophylaxis.\n                  <\/jats:p>","DOI":"10.1111\/j.1600-0447.2008.01257.x","type":"journal-article","created":{"date-parts":[[2008,8,24]],"date-time":"2008-08-24T20:56:18Z","timestamp":1219611378000},"page":"347-356","source":"Crossref","is-referenced-by-count":147,"title":["Long\u2010term antidepressant treatment in bipolar disorder: meta\u2010analyses of benefits and risks"],"prefix":"10.1111","volume":"118","author":[{"given":"S. N.","family":"Ghaemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Filkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Baldessarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_10_2_2","volume-title":"Manic depressive illness","author":"Goodwin F","year":"2007"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.5.638"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0610"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00091.x"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0802"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0910"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1996)4:4<190::AID-DA5>3.0.CO;2-J"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.1.51"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199312000-00005"},{"key":"e_1_2_10_12_2","first-page":"429","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"Baldessarini RJ","year":"2005"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.11.1079"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1351"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00479.x"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.3"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2006.00344.x"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2008.00550.x"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1399-5618.2003.00074.x"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.9.1537"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.6.906"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa064135"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.1.163"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n07a12"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00076-7"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2007.58.1.85"},{"key":"e_1_2_10_29_2","doi-asserted-by":"crossref","DOI":"10.1176\/ps.2008.59.10.1175","article-title":"Use of psychotropic medicines in bipolar disorder patients in the United States: combinations and adherence","author":"Baldessarini RJ","year":"2008","journal-title":"Psychiatr Serv"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004060070035"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-005-0591-9"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462300009570"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.11.1281"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.03.015"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa065779"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00377-8"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.04200030104017"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780330060006"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290090053011"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790220086014"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90054-C"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000171519.64080.c9"},{"issue":"2","key":"e_1_2_10_44_2","first-page":"59","article-title":"Randomized clinical trial of efficacy and safety of long\u2010term antidepressant use in bipolar disorder","volume":"7","author":"Ghaemi SN","year":"2005","journal-title":"Bipolar Disord"},{"issue":"10","key":"e_1_2_10_45_2","first-page":"16","article-title":"Strategies for preventing the recurrence of bipolar disorder","volume":"65","author":"Ghaemi SN","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_10_46_2","volume-title":"Induction of mania by antidepressants. Abstract and powerpoint slides","author":"Tondo L","year":"2008"},{"key":"e_1_2_10_47_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.4.549"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.3.298-a"},{"key":"e_1_2_10_49_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2001.30505.x"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.2.179"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2008.01257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2008.01257.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:15:49Z","timestamp":1697426149000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2008.01257.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1600-0447.2008.01257.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2008.01257.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,9]]}}}